Celyad Oncology

Prospectus ID: DOCREG-2022-000024-03

Document type
Securities note
Home member state
Belgium
Prospectus type
Standalone Prospectus
Structure
Tripartite prospectus with Summary
Approval / filing date
1 Feb 2022
National document ID
SECN-20220702-EN-DOCREG-2022-000024-03-BB1A706F
Issuer LEI
549300ORR0M8XF56OI64
Language(s)
English

ISINs

  • BE0974260896

Passported to

Member states to which this prospectus has been notified under Art. 25 of Regulation (EU) 2017/1129.

  • France

Last verified: 2 Nov 2026

Data sourced from the ESMA prospectus register, updated weekly.

Regulatory Q&As

Browse Prospectus Regulation Q&As → Official ESMA interpretations

See also

Passporting details — 1 host member state → ESMA Prospectus Passporting Register

📋 Track EU financial regulation continuously

Forseti monitors EU financial regulation and delivers personalised alerts anchored to verified official sources.

Start free trial → Learn more

14-day free trial. No credit card required.